Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway in human colon cancer cells.
about
Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cellsNFATc1 regulation of TRAIL expression in human intestinal cellsLithium ions: a novel treatment for pheochromocytomas and paragangliomasRepression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.High fluence low-power laser irradiation induces apoptosis via inactivation of Akt/GSK3β signaling pathway.Ulk1 over-expression in human gastric cancer is correlated with patients' T classification and cancer relapse.GSK3beta: role in therapeutic landscape and development of modulators.Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cellsTriptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.Krüppel-like factor 4 regulates intestinal epithelial cell morphology and polarity.Akt-dependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis.Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiationHIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling.Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNKAnticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cellsARK5 expression in colorectal cancer and its implications for tumor progression.Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitizationCaspases mediate processing of the capsid precursor and cell release of human astrovirusesMolecular mechanisms contributing to glutamine-mediated intestinal cell survival.Microgravity Induction of TRAIL Expression in Preosteoclast Cells Enhances Osteoclast Differentiation.Regulation of PTEN expression in intestinal epithelial cells by c-Jun NH2-terminal kinase activation and nuclear factor-kappaB inhibitionClostridium difficile toxin A binds colonocyte Src causing dephosphorylation of focal adhesion kinase and paxillin.MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.Induction of cIAP-2 in human colon cancer cells through PKC delta/NF-kappa B.Preclinical evaluation of perifosine as a potential promising anti-rhabdomyosarcoma agent.Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity.Perifosine induces cell apoptosis in human osteosarcoma cells: new implication for osteosarcoma therapy?Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization.Sphingosine-1-phosphate protects intestinal epithelial cells from apoptosis through the Akt signaling pathway.Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand.Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression.Akt kinase activation blocks apoptosis in intestinal epithelial cells by inhibiting caspase-3 after polyamine depletion.Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-kappaB-dependent pathway.Signaling through the TRAIL receptor DR5/FADD pathway plays a role in the apoptosis associated with skeletal myoblast differentiation.Tyrosine mutation in CD3epsilon-ITAM blocked T lymphocyte apoptosis mediated by CD3epsilon.The nucleocytoplasmic shuttling of E2F4 is involved in the regulation of human intestinal epithelial cell proliferation and differentiation.Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity.
P2860
Q28265036-C055AAA6-85EC-4D98-8215-E2CB6CA29D52Q28478149-76251CB5-4F7D-4B49-B44E-5F198B5B3DF5Q28582101-6FAB9B09-CC06-4B02-B942-D18030286298Q33288897-7AD1B063-5831-4D57-BEF6-8B213C235D2CQ33648923-8298DFFD-DA79-4DBD-B8CD-E413F9723B4CQ33779645-04BCE8C2-338A-4A04-AB38-F79850A6D7D5Q33812730-E62F1D23-F575-461E-835D-AF5B205285E6Q33980477-06056A69-7A8B-4D87-8CA4-ACE0D937646DQ34173719-2F708259-0227-4565-BCF3-BB0F6A8EB311Q34182752-2EF3883F-761A-4666-99C4-75152BB253B8Q34315725-71BED9FA-9AF7-47BD-90ED-EC9A832A9B60Q34382719-3B8D570A-EBEE-487D-BF62-C5726D221AF8Q34405013-1644E444-E298-4B72-B16B-8989CB5A5025Q34438274-3362580E-1631-46F8-9850-8FC5859F1724Q34568521-E09C244D-DCF5-4FB9-A639-7804F78EE0D0Q35050195-926268A2-BE1C-4A8B-85A1-311C515F3A34Q35060343-5654B45C-00C1-48A4-9274-B30D9B216ECEQ35096069-14D22398-20B3-462C-A024-2B9F8738F379Q35857019-2A6482C2-B188-4CD9-89A0-75B814547A95Q36684035-A87EDBBA-2071-4697-BA08-F54F3DDDBCFFQ36728699-9A01A9FD-411C-452F-AD0A-15953529D62CQ36864686-4D1AB209-5426-401B-856B-024E02A0DEADQ37113710-4DDA1B37-BA95-4140-A2A6-F75AA17470C5Q37438399-6906AD72-384F-4960-BC49-420A9EF5DEC8Q37480580-3C488AAB-A19C-46AD-95AA-629D0AE896B9Q38349616-0D8B5570-001E-4EA8-B827-FE7240897BBEQ38844089-F775AB7B-E3F6-49B7-95DC-6ECDD86F099FQ38866710-458F315E-8501-496D-B06D-F22066FED9A9Q39270813-6F719775-8E3A-4255-B0F8-2204EDECC615Q39601411-A28E8BE1-AB14-43CF-948B-AC86D61BAF9EQ39957450-345F8949-E5AC-42EB-BE8D-108D17AAB29DQ40075397-63350E33-F685-4724-8ED0-F763A5B0A566Q40214713-18649875-53E5-44F1-904C-FF0B1C0ABA4BQ40578104-1D0CF934-5621-4577-8F32-2A1CE518EDA2Q40586194-FD3E9019-C5BD-41F0-9B3C-CF2EC2A23385Q42242386-115AEFB8-0BC0-48AD-8320-B60D4D2154CAQ44424133-EB8B3AF9-A1E7-469F-ACB1-C8315A093D2AQ44811593-09292779-3FC9-4570-844B-335C9768D299Q44904081-399D2440-5E5F-4258-BC43-798C3DBEE362
P2860
Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway in human colon cancer cells.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Regulation of TRAIL expression ...... y in human colon cancer cells.
@en
type
label
Regulation of TRAIL expression ...... y in human colon cancer cells.
@en
prefLabel
Regulation of TRAIL expression ...... y in human colon cancer cells.
@en
P2093
P2860
P356
P1476
Regulation of TRAIL expression ...... y in human colon cancer cells.
@en
P2093
Ambrosio Hernandez
B Mark Evers
Mark R Hellmich
Qingding Wang
Xiaofu Wang
Zoran Gatalica
P2860
P304
36602-36610
P356
10.1074/JBC.M206306200
P407
P577
2002-07-24T00:00:00Z